Sudeep Pharma Secures FDA Approval for 51,200 MT Greenfield Facility
Sudeep Pharma Ltd 路 Press Release 路 26 Oct 2026, 6:01 pm
Sudeep Pharma Secures FDA Approval for 51,200 MT Greenfield Facility Sudeep Pharma Limited received Gujarat FDA approval on 26th Oct'26 to commence operations at its new greenfield facility at 179 Nandesari, Gujarat. The facility adds an annual installed capacity of 51,200 MT, targeting Pharma, Food & Nutrition, and Specialty Ingredients. Around 60% of capacity is allocated to existing product lines, while the remaining 40% will cater to newer, high-value molecules like bisglycinates, phosphates, and gluconates. Following customer qualifications, commercial supplies are slated to commence in H2 FY27.
Original exchange filing (PDF)
More announcements from Sudeep Pharma Ltd
- Submission of Transcript for the Earnings call held on 29.10.2026 路 03 Nov 2026
- Submission of Audio Recording of the Earnings call held on 29th October 2026 路 29 Oct 2026
- Submission of Investors Presentation 路 29 Oct 2026
- Outcome of Board Meeting 路 28 Oct 2026
- Submission of Unaudited Financials Results for the Quarter and half year ended 30th September 2026 路 28 Oct 2026
- Submission of Outcome of Board Meeting 路 28 Oct 2026
- Intimation for the Investor Meet Scheduled to be held on 29th October 2026 at 12:00 noon. 路 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 28 Oct 2026
